BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced a collaboration with ...

During a pregnancy, women are offered prenatal genetic screening and diagnostic testing to determine whether a fetus is healthy or has certain genetic disorders or anomalies. This information can help ...

GeneDx announced GenomeDx Prenatal™, a whole genome sequencing test that delivers fast, comprehensive insights when fetal ...

NEW YORK (Reuters Health) - Normally, parents who want to know the sex of their baby before it's born find out through ultrasound done in the second trimester. A blood test that can be done early in ...

As prenatal genetic testing becomes more common, experts explain what these tests can and cannot predict, how parents should ...

Two professional societies have released comments on the use of cell-free fetal (cff) DNA noninvasive prenatal testing (NIPT) to detect trisomies in low-risk pregnant women. The statements follow ...

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced the launch of Fetal Focus, a noninvasive prenatal test ...

Researchers have developed a non-invasive genetic test that can screen the blood of pregnant individuals to survey all genes from the fetal genome. A team of investigators from Massachusetts General ...

LONDON - JULY 18: (Photo illustration by Daniel Berehulak/Getty Images) Over time, non-invasive screening studies were developed that were easier and safer for pregnant patients. Early versions of ...

A disturbing report from The New York Times on the unreliability of prenatal blood testing for genetic abnormalities should do more than make us wish that the testing companies were better regulated.